Lifotronic Technology Secures New Medical Device Registration Certificate
Stock News
Mar 03
Shenzhen Lifotronic Technology Co., Ltd. (688389.SH) has announced the recent receipt of a Medical Device Registration Certificate for In Vitro Diagnostic Reagents issued by the Guangdong Provincial Medical Products Administration. The newly registered product is an Erythropoietin (EPO) Assay Kit utilizing electrochemiluminescence technology. This kit employs a sandwich chemiluminescence immunoassay method with dual antibodies, offering high sensitivity and precision. The addition of this kit further enriches and completes the company's electrochemiluminescence reagent testing portfolio, which is expected to enhance its market competitiveness in the field of immunodiagnostics.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.